XOMA Royalty (XOMA) Accounts Payables (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Accounts Payables came in at $3.5 million in Q1 2026, up 52.39% year-on-year from $2.3 million in Q1 2025, and up 60.05% quarter-over-quarter from $2.2 million in Q4 2025.

XOMA Royalty (XOMA) Accounts Payables (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Accounts Payables across 17 years of filings, most recently posting $3.5 million for Q1 2026.

  • Accounts Payables for Q1 2026 came in at $3.5 million, up 52.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 52.39% YoY), and the FY2025 annual result was $2.2 million, up 109.69% from the prior year.
  • Accounts Payables came in at $3.5 million for Q1 2026 at XOMA Royalty, up from $2.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $3.5 million in Q1 2026 to a low of $437000.0 in Q1 2023.
  • The 5-year median for Accounts Payables is $1.1 million (2024), against an average of $1.3 million.
  • Across the five-year window, Accounts Payables sank 51.12% in 2022 and jumped 246.68% in 2024, its largest moves.
  • XOMA Royalty's Accounts Payables stood at $524000.0 in 2022, then climbed by 24.62% to $653000.0 in 2023, then jumped by 61.26% to $1.1 million in 2024, then surged by 109.69% to $2.2 million in 2025, then jumped by 60.05% to $3.5 million in 2026.
  • The last three Accounts Payables figures came in at $3.5 million (Q1 2026), $2.2 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 1.05 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 83.00 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 8.64 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 489.30 Mn
9 Abivax 95.45 Bn 95.45 Bn - 34.55 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 3.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.53 Mn
Dec 31, 2025 2.21 Mn
Sep 30, 2025 2.65 Mn
Jun 30, 2025 1.14 Mn
Mar 31, 2025 2.32 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 1.13 Mn
Jun 30, 2024 982,000.00
Mar 31, 2024 1.52 Mn
Dec 31, 2023 653,000.00
Sep 30, 2023 728,000.00
Jun 30, 2023 740,000.00
Mar 31, 2023 437,000.00
Dec 31, 2022 524,000.00
Sep 30, 2022 985,000.00
Jun 30, 2022 1.15 Mn
Mar 31, 2022 787,000.00
Dec 31, 2021 1.07 Mn
Sep 30, 2021 598,000.00
Jun 30, 2021 629,000.00